VAT Group AG Faces Governance Shift & R&D Cutbacks: What It Means for Growth & Liquidity
Analyze VAT GROUP AG’s governance shift, product focus, and cash strain, uncovering risks and strategies for R&D, CapEx, and liquidity in the allergy‑therapy market.
4 minutes to read









